Extracorporeal shockwave lithotripsy in patients treated with antithrombotic agents

Journal of Endourology
G ZanettiE Pisani

Abstract

Between January 1996 and December 1999, 749 patients underwent electromagnetic SWL. Among them, 23 patients, 19 with renal and 4 with ureteral stones, were receiving antithrombotic drugs (aspirin, ticlopidine, dipyridamole). According to the cardiologist and hematologist, we divided these patients into two groups: Group 1 had a low thromboembolic risk (previous myocardial infarction), and Group 2 had a high thromboembolic risk (aortocoronary bypass, atrial fibrillation, cerebrovascular disease, peripheral occlusive arterial disease). Group 1 patients discontinued their antiplatelet therapy 8 days prior to SWL to permit a sufficient number of functioning platelets to remain. Group 2 patients suspended antiplatelet therapy, and unfractioned heparin 5000 IU tid (8 a.m., 4 p.m., and 12 p.m.) was administered for the 8 days prior to SWL. On the ninth day of withdrawal, SWL was performed in all patients. Close follow-up was performed during the postoperative period (hemoglobin, hematocrit, kidney ultrasonography, plain abdominal film). The antithrombotic therapy was restored in all patients within 10 to 14 days of withdrawal. Hematomas and thromboembolic events were not observed. At 3 months' follow-up, 14 patients (61%) were stone f...Continue Reading

References

Sep 1, 1978·Annals of Internal Medicine·M TorosianH MacVaugh
Dec 1, 1978·Annals of Internal Medicine·R N Rubin
Dec 1, 1978·Annals of Internal Medicine·M D Reynolds
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G J RothP W Majerus
Dec 1, 1990·The Journal of Urology·S B Streem, A Yost
May 1, 1989·Urology·J G ChristensenW A Cline
Aug 1, 1987·The Journal of Urology·K L PartneyC R May
Sep 1, 1987·The Journal of Urology·G EconomacosC Dimopoulos
Aug 1, 1985·AJR. American Journal of Roentgenology·J V KaudeB Finlayson
Jan 1, 1996·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·H BevingT Ivert
Sep 1, 1999·BJU International·S M Mitchell, K K Sethia
May 1, 1964·The Journal of Clinical Investigation·R H ASTER, J H JANDL

❮ Previous
Next ❯

Citations

Jan 1, 2003·European Urology·H C KlinglerM Marberger
Dec 19, 2013·Nature Reviews. Urology·Andreas BourdoumisJunaid Masood
Jan 18, 2011·Journal of Endourology·George H TseSarath R K Nalagatla
Mar 24, 2009·AJR. American Journal of Roentgenology·Timotheus T C OvertoomHans P M van Heesewijk
Apr 8, 2011·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Bader Alsaikhan, Sero Andonian
May 24, 2014·Journal of Endourology·Marco J SchnabelHans-Martin Fritsche
Nov 18, 2008·The Journal of Urology·John C KeferMihir M Desai
Jan 4, 2012·Geriatrics & Gerontology International·Fazli PolatIbrahim Bozkirli
May 27, 2014·The Journal of Urology·Daniel J CulkinDeborah J Lightner
Nov 28, 2017·Urolithiasis·Christian G Chaussy, Hans-Göran Tiselius
Mar 1, 2011·Arab Journal of Urology·Prodromos PhilippouNoor Buchholz
Jun 20, 2002·Current Opinion in Urology·Brian K Auge, Glenn M Preminger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.